- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 08, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,622 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €9.00 | 7.7% | 148.6% | €128.6m | €9.70 | PS21.3x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
AGP | €8.30 | 4.9% | 151.5% | €143.7m | €12.75 | PE29.2x | E22.8% | n/a | Capital Goods | ||
ERO | CA$29.32 | 4.3% | 17.1% | CA$2.9b | CA$31.02 | PE35.7x | E25.6% | n/a | Materials | ||
RDUE | €9.50 | 0% | 1.1% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
FDE | €34.50 | 2.1% | -3.2% | €180.4m | €64.07 | PE23x | E37.6% | n/a | Energy | ||
NVG | zł2.15 | 7.5% | 31.5% | zł75.3m | zł3.71 | PE14.9x | E30.8% | n/a | Diversified Financials | ||
KEBNI B | kr1.48 | -6.8% | 40.8% | kr402.4m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
PRL | CA$24.18 | 8.2% | 262.0% | CA$832.2m | CA$24.61 | PE21.8x | E33.6% | 2.0% | Diversified Financials | ||
NEWBRY | kr3.06 | -10.3% | -45.4% | kr74.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
NOHAL | kr23.20 | 2.7% | -9.4% | kr907.3m | kr32.50 | PS8.9x | E56.0% | n/a | Food, Beverage & Tobacco | ||
WAYS | kr21.95 | -2.9% | -53.1% | kr177.1m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
OSE | €6.66 | 18.1% | 71.2% | €143.7m | €7.15 | PS64.5x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
AVLL3 | R$3.78 | 2.7% | 29.5% | R$738.3m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
MVW | kr8.05 | -5.3% | 8.5% | kr263.4m | kr13.00 | PS23.9x | E66.8% | n/a | Materials | ||
APLT | US$4.71 | 6.1% | 185.5% | US$550.6m | US$11.60 | PS53.8x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr112.00 | 1.8% | -12.0% | kr6.0b | kr208.00 | PS5x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$138.67 | 5.3% | 69.9% | US$42.5b | US$147.64 | PE62.5x | E41.9% | 2.7% | Diversified Financials | ||
DIRR3 | R$25.14 | 5.4% | 55.1% | R$4.3b | R$29.18 | PE13.1x | E26.1% | 1.9% | Consumer Durables | ||
GIG | kr31.25 | -8.4% | 12.2% | kr4.0b | kr45.25 | PE18.3x | E37.5% | n/a | Consumer Services | ||
AXSM | US$75.68 | 2.0% | -2.9% | US$3.6b | US$123.56 | PS14.3x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$17.12 | 4.3% | -49.2% | US$2.5b | US$31.50 | PE59.5x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$161.38 | 0.5% | 80.2% | US$9.0b | US$205.92 | PE69.2x | E26.4% | n/a | Household | ||
ELABS | kr15.52 | -0.4% | 37.1% | kr1.6b | kr25.00 | PS23.8x | E124.6% | n/a | Software | ||
NVDA | US$904.12 | 8.9% | 213.0% | US$2.2t | US$1,004.20 | PE74.8x | E23.4% | 0.02% | Semiconductors |